GT Biopharma, Inc. GTBP

Set alert

Price alert · GTBP

All alert types
5.13 USD -0.37 -6.73%

At close · Nov 2

5.25 +0.12 +2.34%

After hours · Nov 2, 4:00 PM ET

Bid
5.11 × 1
Ask
5.17 × 1
5.13 Day range 5.40
0.554 52-week range 20.42
YTD
+553.50%
1 year
+718.18%
Open
5.35
Prev close
5.50
Mkt cap
10.57M
Vol
33.59K
Avg vol
64.70K
EPS
-147.50
P/E
0.00
Div yield
0.00%
More statistics
Low
5.13
High
5.40
Forward P/E
-0.26
Beta
0.57
Short ratio
0.71
Inst. own
67.52%
Dividend
0.00
Ex-div date
Earnings
Apr 4, 2024
50-d avg
2.76
200-d avg
3.00
1y target
11.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for GTBP has not been loaded yet. Try again in a moment.

Analyst view

Consensus: none

Price target (mean) 11.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy0
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 1

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

GTBP analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.000.00 – 0.000.000.0%00.0%0
Next quarter0.000.00 – 0.000.000.0%00.0%0
Current year0.000.00 – 0.000.000.0%00.0%0
Next year0.000.00 – 0.000.000.0%00.0%0

Upgrades and downgrades

The latest rating changes

GTBP analyst upgrades and downgrades
DateFirmActionFromTo
Dec 2, 2024Roth MKMInitiated—Buy